Phase 2b, 12 Week, Double-blind, Placebo-Controlled, Randomized, Parallel-group, MultiCenter Study of the Safety and Efficacy of JZP385 in the Treatment of Adults with Moderate to Severe Essential Tremor
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Cavion, Inc
Start Date
January 5, 2022
End Date
March 31, 2024
Administered By
Neurology, Movement Disorders
Awarded By
Cavion, Inc
Start Date
January 5, 2022
End Date
March 31, 2024